Skip to main content
. Author manuscript; available in PMC: 2020 Oct 8.
Published in final edited form as: Vaccine. 2019 Sep 6;37(43):6463–6469. doi: 10.1016/j.vaccine.2019.08.085

Table 4.

Descriptive analysis (unweighted) of measles seropositivity by vaccination status of doses administered through routine immunization among children – Bhutan, 2017.*

14 years
511 years
1217 years
Total
# of measles-rubella containing vaccine doses received
by card (all ages) or recall (1–4 years) by routine
immunization**
Total # measles
IgG
positive
% Total # measles
IgG
positive
% Total # measles
IgG
positive
% Total # measles
IgG
positive
%
0 3 3 100 6 0 0 5 2 44 14 5 36
1 44 34 74 34 15 46 50 24 42 128 73 57
≥2 123 110 88 128 70 58 3 3 100 254 183 72
Unknown 3 3 100 75 35 50 74 30 41 152 68 45
*

Two children who were reported to be 5–17 years of age did not provide their date of birth, so we could not subcategorize them as belonging to the 5- to 11- or 12- to 17-year-old groups.

**

Among 1–4-year-olds, vaccination history is by documentation or recall. Among 5–17-year-olds, vaccination history is by documentation only. Those 12–17 years of age were not eligible for rubella vaccination through routine immunization.